Clinical Watch: December 2018

January 7, 2019

In this issue of Clinical Watch, we describe expanded uses of Hemlibra® and suggest criteria for the use of Dupixent® to treat severe asthma. We also review a study evaluating factors associated with non-adherence to essential chronic medications. Lastly, we review the prevalence of opioid polypharmacy in two Medicaid pharmacy programs.

For more information about our solutions, please visit conduent.com/pharmacysolutions.

No Previous Flipbooks

Next Article
CompTIA's HSITAG Celebrates 25 Years of Industry-Leading Work
CompTIA's HSITAG Celebrates 25 Years of Industry-Leading Work